Skip to content

ABOCOR: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

ABOCOR

BE 0775.821.440
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€17,009
2024 · -€24,008+€6,999
Equity
€1,718
2024 · €18,727-€17,009
Cash
€3,809
2024 · €9,525-€5,716
Balance sheet total
€10,389
2024 · €18,860-€8,471

Largest movements

2024 to 2025
Assets
  • Cash -€5,716

    down €5,716 (-60.0%), from €9,525 to €3,809

    mainly Net result for the year (-€17,009)

  • Tangible fixed assets -€2,771

    down €2,771 (-31.1%), from €8,910 to €6,140

Equity and liabilities
  • Profit (loss) carried forward -€17,009

    down €17,009, from €16,727 to -€282

  • Other debts +€8,500

    new in 2025: €8,500

Income statement
  • Gross operating margin +€7,697

    up €7,697 (+38.4%), from -€20,066 to -€12,369

  • Other operating charges +€575

    up €575 (+261%), from €220 to €795

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€24,008
Gross operating margin +€7,697
Depreciation -€53
Other operating charges -€575
Financial charges -€63
Taxes -€8
Result 2025 -€17,009
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€5,716
Investment €0
Financing €0
Cash 2024 €9,525
Net result for the year -€17,009
Depreciation +€2,771
Smaller working-capital items +€22
Other debts +€8,500
Cash 2025 €3,809
brings cash intakes cash out
Every line side by side 31 lines
Line Code 2024 2025 Change %
Total assets 20/58 €18,860 €10,389 -€8,471 -44.9%
Fixed assets 21/28 €8,957 €6,186 -€2,771 -30.9%
Tangible fixed assets 22/27 €8,910 €6,140 -€2,771 -31.1%
Furniture and vehicles 24 €8,910 €6,140 -€2,771 -31.1%
Financial fixed assets 28 €47 €47 = 0.0%
Current assets 29/58 €9,903 €4,203 -€5,700 -57.6%
Amounts receivable within one year 40/41 €378 €394 +€16 +4.3%
Other amounts receivable 41 €378 €394 +€16 +4.3%
Cash at bank and in hand 54/58 €9,525 €3,809 -€5,716 -60.0%
Deferred charges and accrued income 490/1 €0 - =
Total equity and liabilities 10/49 €18,860 €10,389 -€8,471 -44.9%
Equity 10/15 €18,727 €1,718 -€17,009 -90.8%
Contributions 10/11 €2,000 €2,000 = 0.0%
Profit (loss) carried forward 14 €16,727 -€282 -€17,009
Amounts payable 17/49 €133 €8,671 +€8,538 +6,405%
Amounts payable within one year 42/48 €133 €8,671 +€8,538 +6,405%
Trade debts 44 €0 €30 +€30
Suppliers 440/4 €0 €30 +€30
Taxes, remuneration and social security 45 €133 €141 +€8 +5.7%
Taxes 450/3 €133 €141 +€8 +5.7%
Other amounts payable 47/48 - €8,500 +€8,500
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €2,718 €2,771 +€53 +2.0%
Other operating charges 640/8 €220 €795 +€575 +261%
Gross operating margin 9900 -€20,066 -€12,369 +€7,697 +38.4%
Operating profit (loss) 9901 -€23,004 -€15,934 +€7,069 +30.7%
Financial charges 65/66B €871 €934 +€63 +7.2%
Recurring financial charges 65 €871 €934 +€63 +7.2%
Profit (loss) for the period before taxes 9903 -€23,875 -€16,868 +€7,007 +29.3%
Income taxes 67/77 €133 €141 +€8 +5.7%
Profit (loss) for the period 9904 -€24,008 -€17,009 +€6,999 +29.2%
Profit (loss) for the period to be appropriated 9905 -€24,008 -€17,009 +€6,999 +29.2%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 13 October 2026 via checked.be.